SCHEMBL276837

SCHEMBL276837

CCCCC(C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12196153 1.00
SCHEMBL8194495 1.00
Hydrochloric Acid SCHEMBL7409622 0.98 CA2 (0.56)
SCHEMBL1827755 0.93 CA1 (0.61)
SCHEMBL1827758 0.93 CA1 (0.61)
SCHEMBL122044 0.93 CA1 (0.61)
Formic Acid SCHEMBL29184482 0.91 CA1 (0.50)
SCHEMBL18229264 0.91 CA1 (0.50)
SCHEMBL23857835 0.91 CA1 (0.59)
SCHEMBL10866301 0.91 CA1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 591 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118165070-A Salt and crystal form of 3CL protease small molecule inhibitor, and preparation methods and applications thereof 北京华益健康药物研究中心 2024-06-11 CN claimed
CN-114681443-B Nitrile-containing antiviral compounds 辉瑞大药厂 2024-05-10 CN claimed
CN-117979991-A Methods for treating, ameliorating or preventing infections using drug and vaccination combination therapy 拓比利亚欧斯特有限公司(ACN 652 771 670) 2024-05-03 CN claimed
CN-117858867-A SARS-COV-2 MPRO inhibitor compounds 赫普泰雅治疗有限公司 2024-04-09 CN claimed
CN-117794896-A Protease inhibitors for the treatment of coronavirus infections 斯克里普斯研究学院 2024-03-29 CN claimed
EP-4337179-A1 METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT Topelia Aust Limited (ACN 652 771 670) (AU) 2024-03-20 EP claimed
EP-4313305-A1 SARS-COV-2 MPRO INHIBITOR COMPOUNDS Heptares Therapeutics Limited (GB) 2024-02-07 EP claimed
CN-116789648-A Nitrile-containing antiviral compounds 辉瑞大药厂 2023-09-22 CN claimed
CN-116600698-A Computerized decision support tool and medical device for respiratory condition monitoring and care 辉瑞公司 2023-08-15 CN claimed
CN-111601798-B Bisamide sarcomere activating compounds and uses thereof 美国安进公司 2023-08-11 CN claimed
CN-102573879-A Cathepsin C inhibitors GLAXO GROUP LTD 2012-07-11 CN claimed
CN-101374823-A Organic compounds NOVARTIS AG (CH) 2009-02-25 CN claimed
CN-100427477-C Process of synthesizing cyclic carbonate by epoxy compound with carbon dioxide reaction NINGBO WANHUA POLYURETHANE CO (CN) 2008-10-22 CN claimed
CN-101014328-A Novel biaromatic compounds which activate receptors of PPAR type and their use in cosmetic or pharmaceutical compositions GALDERMA RES & DEV (FR) 2007-08-08 CN claimed
CN-100999514-A Process of synthesizing cyclic carbonate by epoxy compound with carbon dioxide reaction NINGBO WANHUA POLYURETHANE CO (CN) 2007-07-18 CN claimed
US-20030049807-A1 Micro-organism possessing enantioselective and regioselective nitrile hydratase/amidase activities INSTITUTO BIOCHIMICO ITALIANO GIOVANNI LOREZINI S.P.A. (IT) 2003-03-13 US claimed
EP-1291435-A2 A micro-organism possessing enantioselective and regioselective nitrile hydratase/amidase activities ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. (IT) 2003-03-12 EP claimed
CN-1197452-A Azetidinone derivatives for treatment of atherosclerosis SMITHKLINE BEECHAM PLC (GB) 1998-10-28 CN claimed
CN-1071434-A RETROVIRAL PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 1993-04-28 CN claimed
EP-0383635-A2 Peptides having renin inhibitory activity their preparation and use Sankyo Company Limited (JP) 1990-08-22 EP claimed